Cartesian Growth Corp III Files Q2 2025 10-Q

TL;DR

**Cartesian Growth Corp III 10-Q filed: Q2 2025 financials out, focus on warrants & share redemption.**

AI Summary

Cartesian Growth Corp III filed its 10-Q for the period ending June 30, 2025. The filing details financial information and business operations. Key dates mentioned include May 5, 2025, related to public warrants and measurement inputs, and June 30, 2025, for Class A ordinary shares subject to possible redemption.

Why It Matters

This 10-Q filing provides investors with an update on Cartesian Growth Corp III's financial health and operational status as of mid-2025.

Risk Assessment

Risk Level: medium — As a SPAC (Special Purpose Acquisition Company), Cartesian Growth Corp III faces inherent risks related to its business combination efforts and potential redemption of shares.

Key Numbers

• N/A — Financials (Specific dollar amounts for revenue, profit, or assets were not readily available in the provided text snippet.)
• 2025-06-30 — Reporting Period End Date (Indicates the end of the fiscal quarter for which the report is filed.)

Key Players & Entities

• Cartesian Growth Corp III (company) — Filer of the 10-Q
• 2025-06-30 (date) — End of the reporting period
• 2025-08-15 (date) — Filing date of the 10-Q
• 2025-05-05 (date) — Date related to public warrants and measurement inputs

FAQ

Key Financial Figures

• $0.0001 — LC Class A ordinary shares, par value $0.0001 per share CGCT The Nasdaq Stock Mar
• $11.50 — ordinary share at an exercise price of $11.50 CGCTW The Nasdaq Stock Market LLC

Filing Documents

• tmb-20250630x10q.htm (10-Q) — 779KB
• tmb-20250630xex31d1.htm (EX-31.1) — 11KB
• tmb-20250630xex31d2.htm (EX-31.2) — 11KB
• tmb-20250630xex32d1.htm (EX-32.1) — 5KB
• tmb-20250630xex32d2.htm (EX-32.2) — 6KB
• 0001410578-25-001828.txt ( ) — 4620KB
• tmb-20250630.xsd (EX-101.SCH) — 47KB
• tmb-20250630_cal.xml (EX-101.CAL) — 21KB
• tmb-20250630_def.xml (EX-101.DEF) — 204KB
• tmb-20250630_lab.xml (EX-101.LAB) — 333KB
• tmb-20250630_pre.xml (EX-101.PRE) — 296KB
• tmb-20250630x10q_htm.xml (XML) — 636KB

Financial Information

Part I. Financial Information

Financial Statements

Item 1. Financial Statements Condensed Balance Sheets as of June 30, 2025 (Unaudited) and December 31, 2024 1 Condensed Statements of Operations For the Three and Six Months Ended June 30, 2025 (Unaudited) 2 Condensed Statements of Changes in Shareholders' Deficit For the Three and Six Months Ended June 30, 2025 (Unaudited) 3 Condensed Statement of Cash Flows For the Six Months ended June 30, 2025 (Unaudited) 4 Notes to Condensed Financial Statements (Unaudited) 5

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 20

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 23

Controls and Procedures

Item 4. Controls and Procedures 23

Other Information

Part II. Other Information

Legal Proceedings

Item 1. Legal Proceedings 24

Risk Factors

Item 1A. Risk Factors 24

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 24

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities 25

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 25

Other Information

Item 5. Other Information 25

Exhibits

Item 6. Exhibits 26

Signatures

Signatures 27 Table of Contents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements. CARTESIAN GROWTH CORPORATION III CONDENSED BALANCE SHEETS June 30, December 31, 2025 2024 (Unaudited) Assets Current assets Cash $ 827,241 $ — Prepaid insurance - current 112,307 — Prepaid expenses 20,540 3,202 Total current assets 960,088 3,202 Deferred offering costs — 263,676 Prepaid insurance – long term 93,589 — Investments held in Trust Account 277,767,744 — Total Assets $ 278,821,421 $ 266,878 Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders' Deficit Current Liabilities Accrued offering costs $ 75,000 $ 242,872 Accrued expenses 346,792 — Promissory note – related party — 41,626 Total current liabilities 421,792 284,498 Deferred underwriting fee 13,140,000 — Total Liabilities 13,561,792 284,498 Commitments and Contingencies (Note 6) Class A ordinary shares subject to possible redemption, 27,600,000 shares at redemption value of approximately $ 10.06 and $ 0 per share as of June 30, 2025 and December 31, 2024, respectively 277,767,744 — Shareholders' Deficit Preference shares, $ 0.0001 par value; 1,000,000 shares authorized; none issued and outstanding — — Class A ordinary shares, $ 0.0001 par value; 200,000,000 shares authorized; none issued and outstanding (excluding 27,600,000 and 0 shares subject to possible redemption as of June 30, 2025 and December 31, 2024, respectively) — — Class B ordinary shares, $ 0.0001 par value; 20,000,000 shares authorized; 6,900,000 shares issued and outstanding as of June 30, 2025 and December 31, 2024 690 690 Additional paid-in capital — 24,310 Accumulated deficit ( 12,508,805 ) ( 42,620 ) Total Shareholders' Deficit ( 12,508,115 ) ( 17,620 ) Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders' Deficit $ 278,821,421 $ 266,878 The accompanying notes are an integral part of the unaudi

View Full Filing

View this 10-Q filing on SEC EDGAR